v3.25.2
Equity Method Investments (Tables)
 6 Months Ended
Jun. 30, 2025
Equity Method Investments [Abstract]  
Schedule of Summary Balance Sheet Information Adovate’s summary balance sheet information as of March 31, 2025 and September 30, 2024 is below:
   March 31,
2025		   September 30,
2024		 
Current Assets  $641,245   $1,676,591 
Non-current assets  $3,469,291   $3,506,713 
Current liabilities  $751,327   $537,303 
Non-current liabilities  $1,980,061   $929,156 
Schedule of Operations

Results for Adovate’s operations in the three and six months ended March 31, 2025 and 2024 are summarized below:

 

   Three months 
   2025   2024 
Revenues  $
—
   $
—
 
Costs and expenses   (858,320)   (390,139)
Loss from operations   (858,320)   (390,139)
Other income (expenses)   (36,081)   244,424 
Net loss  $(894,401)  $(145,715)

 

   Six months 
   2025   2024 
Revenues  $
—
   $
—
 
Costs and expenses   (2,130,945)   (1,284,788)
Loss from operations   (2,130,945)   (1,284,788)
Other income (expenses)   (206,753)   164,700 
Net loss  $(2,337,698)  $(1,120,088)
Schedule of Equity Method Investment

Activity recorded for the Company’s equity method investment in Adovate during the six months ended June 30, 2025 is summarized in the following table:

 

Equity investment carrying amount at January 1, 2025  $981,830 
Portion of operating losses recognized   (163,090)
Equity investment carrying amount at March 31, 2025   818,740 
Portion of operating losses recognized   (98,730)
Equity investment carrying amount at June 30, 2025  $720,010